Outcome measures of disease activity for rare autoimmune rheumatic diseases

被引:1
作者
Jones, Alexis [1 ]
Cotton, Alice [1 ]
Guinto, Jesusa [1 ]
Wilton, James [1 ]
Ciurtin, Coziana [1 ]
机构
[1] Univ Coll London Hosp NHS Trust, Dept Rheumatol, London NW1 2PQ, England
关键词
SYSTEMIC-LUPUS-ERYTHEMATOSUS; PRIMARY-SJOGRENS-SYNDROME; IDIOPATHIC INFLAMMATORY MYOPATHIES; HEALTH-ASSESSMENT QUESTIONNAIRE; PRIMARY SJGRENS-SYNDROME; PATIENT REPORTED INDEX; QUALITY-OF-LIFE; DAMAGE INDEX; CLINICAL-TRIALS; CUTANEOUS DERMATOMYOSITIS;
D O I
10.12968/hmed.2018.79.7.396
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Systemic lupus erythematosus, scleroderma, myositis and Sjogren's syndrome are rare, complex, multi-systemic rheumatic diseases associated with significant morbidity and mortality. Thorough assessments of disease activity are required to guide clinical management and assess response to new therapies in clinical trials. This article reviews the commonly used outcome measures to assess this group of diseases and discusses the limitations of their use.
引用
收藏
页码:396 / 401
页数:6
相关论文
共 30 条
[1]   Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease -: A randomized, controlled trial [J].
Badesch, DB ;
Tapson, VF ;
McGoon, MD ;
Brundage, BH ;
Rubin, LJ ;
Wigley, FM ;
Rich, S ;
Barst, RJ ;
Barrett, PS ;
Kral, KM ;
Jöbsis, MM ;
Loyd, JE ;
Murali, S ;
Frost, A ;
Girgis, R ;
Bourge, RC ;
Ralph, DD ;
Elliott, CG ;
Hill, NS ;
Langleben, D ;
Schilz, RJ ;
McLaughlin, VV ;
Robbins, IM ;
Groves, BM ;
Shapiro, S ;
Medsger, TA ;
Gaine, SP ;
Horn, E ;
Decker, JC ;
Knobil, K .
ANNALS OF INTERNAL MEDICINE, 2000, 132 (06) :425-+
[2]   The Sjogren's Syndrome Damage Index - a damage index for use in clinical trials and observational studies in primary Sjogren's syndrome [J].
Barry, R. J. ;
Sutcliffe, N. ;
Isenberg, D. A. ;
Price, E. ;
Goldblatt, F. ;
Adler, M. ;
Canavan, A. ;
Hamburger, J. ;
Richards, A. ;
Regan, M. ;
Gadsby, K. ;
Rigby, S. ;
Jones, A. ;
Mathew, R. ;
Mulherin, D. ;
Stevenson, A. ;
Nightingale, P. ;
Rauz, S. ;
Bowman, S. J. .
RHEUMATOLOGY, 2008, 47 (08) :1193-1198
[3]   Sjogrens Systemic Clinical Activity Index (SCAI)a systemic disease activity measure for use in clinical trials in primary Sjgrens syndrome [J].
Bowman, S. J. ;
Sutcliffe, N. ;
Isenberg, D. A. ;
Goldblatt, F. ;
Adler, M. ;
Price, E. ;
Canavan, A. ;
Hamburger, J. ;
Richards, A. ;
Rauz, S. ;
Regan, M. ;
Gadsby, K. ;
Rigby, S. ;
Jones, A. ;
Mathew, R. ;
Mulherin, D. ;
Stevenson, A. ;
Nightingale, P. .
RHEUMATOLOGY, 2007, 46 (12) :1845-1851
[4]   Patient-reported outcomes in primary Sjgrens syndrome: comparison of the long and short versions of the Profile of Fatigue and DiscomfortSicca Symptoms Inventory [J].
Bowman, S. J. ;
Hamburger, J. ;
Richards, A. ;
Barry, R. J. ;
Rauz, S. .
RHEUMATOLOGY, 2009, 48 (02) :140-143
[5]  
Castrejón I, 2014, CLIN EXP RHEUMATOL, V32, pS85
[6]   The EULAR Sjogren's syndrome patient reported index as an independent determinant of health-related quality of life in primary Sjogren's syndrome patients: in comparison with non-Sjogren's sicca patients [J].
Cho, Hyon Joung ;
Yoo, Jong Jin ;
Yun, Chan Young ;
Kang, Eun Ha ;
Lee, Hyo-Jung ;
Hyon, Joon Young ;
Song, Yeong Wook ;
Lee, Yun Jong .
RHEUMATOLOGY, 2013, 52 (12) :2208-2217
[7]  
CLEMENTS P, 1995, J RHEUMATOL, V22, P1281
[8]   Aberrant expression of BAFF by B lymphocytes infiltrating the salivary glands of patients with primary Sjogren's syndrome [J].
Daridon, Capucine ;
Devauchelle, Valerie ;
Hutin, Pascal ;
Le Berre, Rozenn ;
Martins-Carvalho, Christine ;
Bendaoud, Boutahar ;
Dueyrnes, Maryvonne ;
Saraux, Alain ;
Youinou, Pierre ;
Pers, Jacques-Olivier .
ARTHRITIS AND RHEUMATISM, 2007, 56 (04) :1134-1144
[9]   PRIMARY SJOGREN SYNDROME - CLINICAL AND IMMUNOPATHOLOGIC FEATURES [J].
FOX, RI ;
HOWELL, FV ;
BONE, RC ;
MICHELSON, P .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 1984, 14 (02) :77-105
[10]   MEASUREMENT OF PATIENT OUTCOME IN ARTHRITIS [J].
FRIES, JF ;
SPITZ, P ;
KRAINES, RG ;
HOLMAN, HR .
ARTHRITIS AND RHEUMATISM, 1980, 23 (02) :137-145